Release Date: 21/01/20 10:13 Summary: HY20 results release date and investor call details Price Sensitive: No Download Document 318.07KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%